arrow
Y

Yan W. Asmann

Mayo Clinic
H指数:65
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults

脑脊液和血浆脂质组学分析预测认知正常老年人认知障碍的风险

2026-10-270
OA
A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

一种用于检测浆细胞异常中驱动突变、重排和拷贝数异常的下一代测序检测方法

2026-03-280
OAAI
Brain transcriptomics highlight abundant gene expression and splicing alterations in non-neuronal cells in aFTLD-U

脑转录组学揭示了aFTLD-U中非神经元细胞中丰富的基因表达和剪接改变。

2025-08-100
OAAI
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing

FTLD-TDP前额皮质剪接景观的分析揭示了亚型特异模式及隐匿剪接。

2025-06-060
OAAI
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing

通过全基因组测序破译ftld-tdp病理亚型的不同遗传危险因素

2025-04-250
OA
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)

11 q13.3的功能变体rs9344调节t(11;14) 多发性骨髓瘤中CCND1的表达

LEUKEMIA
IF13.4
2024-10-140
OAAI
Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
2024-08-091
OAAI
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
2024-08-080
OAAI
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
2024-06-202
OAAI
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
2024-04-053
OAAI
LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4
2023-04-1013
OA